Zist Arvand

Arvand Pharmed, also known as Zist Arvand Pharmed, is a leading Iranian pharmaceutical and biotechnology company specializing in the development and manufacturing of high-tech generic medicines and biosimilars. The company focuses on complex therapeutic areas including oncology, hematology, neurology, and autoimmune diseases, providing affordable alternatives to expensive international brands. Arvand Pharmed operates advanced manufacturing facilities that comply with international GMP standards, enabling the production of oral solids, injectables, and biotechnological products. Their portfolio includes generic versions of blockbuster drugs such as abiraterone, lenalidomide, and various tyrosine kinase inhibitors, as well as biosimilar developments in the peptide and monoclonal antibody space. By leveraging local R&D and strategic partnerships, the company plays a critical role in the Middle Eastern healthcare market, particularly in ensuring access to life-saving treatments under economic constraints.